| Year |
Citation |
Score |
| 2023 |
Zouaoui I, Dumais A, Lavoie ME, Potvin S. Auditory Steady-State Responses in Schizophrenia: An Updated Meta-Analysis. Brain Sciences. 13. PMID 38137170 DOI: 10.3390/brainsci13121722 |
0.349 |
|
| 2023 |
Pilon F, Boisvert M, Potvin S. Losing the chain of thought: A meta-analysis of functional neuroimaging studies using verbal tasks in schizophrenia. Journal of Psychiatric Research. 169: 238-246. PMID 38048673 DOI: 10.1016/j.jpsychires.2023.11.013 |
0.31 |
|
| 2023 |
Athanassiou M, Dumais A, Zouaoui I, Potvin S. The clouded debate: A systematic review of comparative longitudinal studies examining the impact of recreational cannabis legalization on key public health outcomes. Frontiers in Psychiatry. 13: 1060656. PMID 36713920 DOI: 10.3389/fpsyt.2022.1060656 |
0.725 |
|
| 2022 |
Fortier A, Dumais A, Athanassiou M, Tikàsz A, Potvin S. Dysconnectivity between the anterior insula and the dorsal anterior cingulate cortex during an emotion go/nogo paradigm is associated with aggressive behaviors in male schizophrenia patients. Psychiatry Research. Neuroimaging. 328: 111579. PMID 36469978 DOI: 10.1016/j.pscychresns.2022.111579 |
0.756 |
|
| 2022 |
Zhornitsky S, Tourjman V, Pelletier J, Assaf R, Li CR, Potvin S. Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 118: 110575. PMID 35568275 DOI: 10.1016/j.pnpbp.2022.110575 |
0.59 |
|
| 2022 |
Athanassiou M, Dumais A, Tikasz A, Lipp O, Dubreucq JL, Potvin S. Increased cingulo-orbital connectivity is associated with violent behaviours in schizophrenia. Journal of Psychiatric Research. 147: 183-189. PMID 35051717 DOI: 10.1016/j.jpsychires.2022.01.001 |
0.775 |
|
| 2021 |
Zhornitsky S, Chaudhary S, Le TM, Chen Y, Zhang S, Potvin S, Chao HH, van Dyck CH, Li CR. Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis. Psychiatry Research. Neuroimaging. 317: 111380. PMID 34482052 DOI: 10.1016/j.pscychresns.2021.111380 |
0.566 |
|
| 2021 |
Athanassiou M, Dumais A, Gnanhoue G, Abdel-Baki A, Jutras-Aswad D, Potvin S. A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders. Expert Review of Neurotherapeutics. PMID 34120548 DOI: 10.1080/14737175.2021.1942845 |
0.76 |
|
| 2021 |
Le TM, Potvin S, Zhornitsky S, Li CR. Distinct patterns of prefrontal cortical disengagement during inhibitory control in addiction: A meta-analysis based on population characteristics. Neuroscience and Biobehavioral Reviews. 127: 255-269. PMID 33933507 DOI: 10.1016/j.neubiorev.2021.04.028 |
0.602 |
|
| 2021 |
Potvin S, Giguère CÉ, Mendrek A. Functional Connectivity During Visuospatial Processing in Schizophrenia: A Classification Study Using Lasso Regression. Neuropsychiatric Disease and Treatment. 17: 1077-1087. PMID 33888984 DOI: 10.2147/NDT.S304434 |
0.327 |
|
| 2021 |
Dugré JR, Dumais A, Tikasz A, Mendrek A, Potvin S. Functional connectivity abnormalities of the long-axis hippocampal subregions in schizophrenia during episodic memory. Npj Schizophrenia. 7: 19. PMID 33658524 DOI: 10.1038/s41537-021-00147-2 |
0.31 |
|
| 2021 |
Athanassiou M, Dumais A, Iammatteo V, De Benedictis L, Dubreucq JL, Potvin S. The processing of angry faces in schizophrenia patients with a history of suicide: An fMRI study examining brain activity and connectivity. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 107: 110253. PMID 33485961 DOI: 10.1016/j.pnpbp.2021.110253 |
0.769 |
|
| 2020 |
Dellazizzo L, Potvin S, Athanassiou M, Dumais A. Violence and Cannabis Use: A Focused Review of a Forgotten Aspect in the Era of Liberalizing Cannabis. Frontiers in Psychiatry. 11: 567887. PMID 33192691 DOI: 10.3389/Fpsyt.2020.567887 |
0.754 |
|
| 2020 |
Dugré JR, Radua J, Carignan-Allard M, Dumais A, Rubia K, Potvin S. Neurofunctional Abnormalities in Antisocial Spectrum: A Meta-analysis of fMRI studies on Five distinct Neurocognitive Research Domains. Neuroscience and Biobehavioral Reviews. PMID 32956690 DOI: 10.1016/J.Neubiorev.2020.09.013 |
0.303 |
|
| 2020 |
Luigi M, Dellazizzo L, Giguère CÉ, Goulet MH, Potvin S, Dumais A. Solitary Confinement of Inmates Associated With Relapse Into Any Recidivism Including Violent Crime: A Systematic Review and Meta-Analysis. Trauma, Violence & Abuse. 1524838020957983. PMID 32935639 DOI: 10.1177/1524838020957983 |
0.31 |
|
| 2020 |
Dellazizzo L, Potvin S, Luigi M, Dumais A. Evidence on Virtual Reality-Based Therapies for Psychiatric Disorders: Meta-Review of Meta-Analyses. Journal of Medical Internet Research. 22: e20889. PMID 32812889 DOI: 10.2196/20889 |
0.321 |
|
| 2020 |
Zhornitsky S, Pelletier J, Assaf R, Giroux S, Li CR, Potvin S. Acute effects of partial CB receptor agonists on cognition - A meta-analysis of human studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110063. PMID 32791166 DOI: 10.1016/J.Pnpbp.2020.110063 |
0.615 |
|
| 2020 |
Potvin S, Mahrouche L, Assaf R, Chicoine M, Giguère CÉ, Furtos A, Godbout R. Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting. Frontiers in Psychiatry. 11: 628. PMID 32695035 DOI: 10.3389/Fpsyt.2020.00628 |
0.434 |
|
| 2020 |
Dugré JR, Dumais A, Potvin S. Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: Response to Rasetti et al. The American Journal of Psychiatry. 177: 640-641. PMID 32605444 DOI: 10.1176/Appi.Ajp.2020.19090973R |
0.325 |
|
| 2020 |
Beaudoin M, Potvin S, Giguère CE, Discepola SL, Dumais A. Persistent cannabis use as an independent risk factor for violent behaviors in patients with schizophrenia. Npj Schizophrenia. 6: 14. PMID 32393793 DOI: 10.1038/s41537-020-0104-x |
0.378 |
|
| 2020 |
Abdel-Baki A, Medrano S, Maranda C, Ladouceur M, Tahir R, Stip E, Potvin S. Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis. International Clinical Psychopharmacology. PMID 32282448 DOI: 10.1097/Yic.0000000000000310 |
0.358 |
|
| 2020 |
Tikàsz A, Potvin S, Dugré JR, Fahim C, Zaharieva V, Lipp O, Mendrek A, Dumais A. Violent Behavior Is Associated With Emotion Salience Network Dysconnectivity in Schizophrenia. Frontiers in Psychiatry. 11: 143. PMID 32180744 DOI: 10.3389/Fpsyt.2020.00143 |
0.417 |
|
| 2020 |
Zhornitsky S, Le TM, Dhingra I, Adkinson BD, Potvin S, Li CR. Interpersonal Risk Factors for Suicide in Cocaine Dependence: Association with Self-Esteem, Personality Traits, and Childhood Abuse. Suicide & Life-Threatening Behavior. e12621. PMID 32030810 DOI: 10.1111/Sltb.12621 |
0.61 |
|
| 2020 |
Lecomte T, Giguère CÉ, Cloutier B, Potvin S. Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry. Journal of Dual Diagnosis. 1-11. PMID 31983294 DOI: 10.1080/15504263.2020.1713425 |
0.331 |
|
| 2020 |
Dumont M, Briand C, Leblanc Y, Aubin G, Potvin S, Dumais A. The Integrated Psychological Treatment for Individuals With Schizophrenia in Correctional and Forensic Psychiatric Settings: An Implementation Study. International Journal of Offender Therapy and Comparative Criminology. 306624X19899607. PMID 31941403 DOI: 10.1177/0306624X19899607 |
0.37 |
|
| 2019 |
Potvin S, Gamache L, Lungu O. A Functional Neuroimaging Meta-Analysis of Self-Related Processing in Schizophrenia. Frontiers in Neurology. 10: 990. PMID 31572296 DOI: 10.3389/Fneur.2019.00990 |
0.382 |
|
| 2019 |
Dugré JR, Bitar N, Dumais A, Potvin S. Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind. The American Journal of Psychiatry. appiajp201919030247. PMID 31509006 DOI: 10.1176/Appi.Ajp.2019.19030247 |
0.342 |
|
| 2019 |
Lecomte T, Potvin S, Samson C, Francoeur A, Hache-Labelle C, Gagné S, Boucher J, Bouchard M, Mueser KT. Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence. Journal of Abnormal Psychology. PMID 31343181 DOI: 10.1037/Abn0000447 |
0.388 |
|
| 2019 |
Dellazizzo L, Potvin S, Bahig S, Dumais A. Comprehensive review on virtual reality for the treatment of violence: implications for youth with schizophrenia. Npj Schizophrenia. 5: 11. PMID 31337763 DOI: 10.1038/s41537-019-0079-7 |
0.32 |
|
| 2019 |
Beaudoin M, Potvin S, Dellazizzo L, Luigi M, Giguère CE, Dumais A. Trajectories of Dynamic Risk Factors as Predictors of Violence and Criminality in Patients Discharged From Mental Health Services: A Longitudinal Study Using Growth Mixture Modeling. Frontiers in Psychiatry. 10: 301. PMID 31139099 DOI: 10.3389/Fpsyt.2019.00301 |
0.34 |
|
| 2019 |
Pennou A, Lecomte T, Potvin S, Khazaal Y. Mobile Intervention for Individuals With Psychosis, Dual Disorders, and Their Common Comorbidities: A Literature Review. Frontiers in Psychiatry. 10: 302. PMID 31130884 DOI: 10.3389/Fpsyt.2019.00302 |
0.382 |
|
| 2019 |
Abdel-Baki A, Thibault D, Medrano S, Stip E, Ladouceur M, Tahir R, Potvin S. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder. Early Intervention in Psychiatry. PMID 31125513 DOI: 10.1111/Eip.12826 |
0.401 |
|
| 2019 |
Dugré JR, Giguére CÉ, Percie du Sert O, Potvin S, Dumais A. The Psychometric Properties of a Short UPPS-P Impulsive Behavior Scale Among Psychiatric Patients Evaluated in an Emergency Setting. Frontiers in Psychiatry. 10: 139. PMID 30967798 DOI: 10.3389/Fpsyt.2019.00139 |
0.308 |
|
| 2019 |
Tikàsz A, Dumais A, Lipp O, Stip E, Lalonde P, Laurelli M, Lungu O, Potvin S. Reward-related decision-making in schizophrenia: A multimodal neuroimaging study. Psychiatry Research. Neuroimaging. 286: 45-52. PMID 30897449 DOI: 10.1016/J.Pscychresns.2019.03.007 |
0.441 |
|
| 2019 |
Dellazizzo L, Potvin S, Beaudoin M, Luigi M, Dou BY, Giguère CÉ, Dumais A. Cannabis use and violence in patients with severe mental illnesses: A meta-analytical investigation. Psychiatry Research. 274: 42-48. PMID 30780061 DOI: 10.1016/J.Psychres.2019.02.010 |
0.322 |
|
| 2019 |
Lecomte T, Théroux L, Paquin K, Potvin S, Achim A. Can Social Anxiety Impact Facial Emotion Recognition in Schizophrenia? The Journal of Nervous and Mental Disease. PMID 30720605 DOI: 10.1097/Nmd.0000000000000934 |
0.306 |
|
| 2019 |
Lungu O, Potvin S. S164. A Functional Neuroimaging Meta-Analysis of Self-Related Processing in Schizophrenia Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.915 |
0.373 |
|
| 2019 |
Godbout R, Furtos A, Potvin S. F197. Plasma Levels of Anandamide Are Strongly increased in Schizophrenia Patients in the Acute Phase of Illness Biological Psychiatry. 85: S289-S290. DOI: 10.1016/J.Biopsych.2019.03.734 |
0.355 |
|
| 2019 |
Tikasz A, Dumais A, Lungu O, Potvin S. T194. Reward-Related Decision-Making in Schizophrenia: A Multimodal Neuroimaging Study Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.517 |
0.337 |
|
| 2018 |
Potvin S, Dugré JR, Fahim C, Dumais A. Increased Connectivity Between the Nucleus Accumbens and the Default Mode Network in Patients With Schizophrenia During Cigarette Cravings. Journal of Dual Diagnosis. 1-8. PMID 30445892 DOI: 10.1080/15504263.2018.1526432 |
0.41 |
|
| 2018 |
Tourjman SV, Potvin S, Corbalan F, Djouini A, Purdon SE, Stip E, Juster RP, Kouassi E. Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatry. Attention Deficit and Hyperactivity Disorders. PMID 30225804 DOI: 10.1007/S12402-018-0268-7 |
0.312 |
|
| 2018 |
Dellazizzo L, Percie du Sert O, Phraxayavong K, Potvin S, O'Connor K, Dumais A. Exploration of the dialogue components in Avatar Therapy for schizophrenia patients with refractory auditory hallucinations: A content analysis. Clinical Psychology & Psychotherapy. PMID 30221431 DOI: 10.1002/Cpp.2322 |
0.363 |
|
| 2018 |
Lecomte T, Dumais A, Dugré JR, Potvin S. The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis. Psychiatry Research. 268: 189-192. PMID 30041133 DOI: 10.1016/J.Psychres.2018.05.033 |
0.337 |
|
| 2018 |
Dellazizzo L, Potvin S, Phraxayavong K, Lalonde P, Dumais A. Avatar Therapy for Persistent Auditory Verbal Hallucinations in an Ultra-Resistant Schizophrenia Patient: A Case Report. Frontiers in Psychiatry. 9: 131. PMID 29713292 DOI: 10.3389/Fpsyt.2018.00131 |
0.409 |
|
| 2018 |
Potvin S, Tikàsz A, Richard-Devantoy S, Lungu O, Dumais A. History of Suicide Attempt Is Associated with Reduced Medial Prefrontal Cortex Activity during Emotional Decision-Making among Men with Schizophrenia: An Exploratory fMRI Study. Schizophrenia Research and Treatment. 2018: 9898654. PMID 29686902 DOI: 10.1155/2018/9898654 |
0.43 |
|
| 2018 |
Tourjman SV, Juster RP, Purdon S, Stip E, Kouassi E, Potvin S. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression. International Journal of Psychiatry in Clinical Practice. 1-8. PMID 29553848 DOI: 10.1080/13651501.2018.1450512 |
0.302 |
|
| 2018 |
du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, Lalonde P, Phraxayavong K, O'Connor K, Pelletier JF, Boukhalfi T, Renaud P, Dumais A. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial. Schizophrenia Research. PMID 29486956 DOI: 10.1016/J.Schres.2018.02.031 |
0.432 |
|
| 2018 |
Potvin S, Pelletier J, Grot S, Hébert C, Barr A, Lecomte T. Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis. Addictive Behaviors. 80: 154-160. PMID 29407687 DOI: 10.1016/J.Addbeh.2018.01.021 |
0.345 |
|
| 2018 |
Dumont M, Thériault J, Briand C, Dumais A, Potvin S. Psychosocial approaches for individuals with schizophrenia in correctional and forensic psychiatric settings: a rapid review The Journal of Forensic Practice. 20: 152-166. DOI: 10.1108/Jfp-11-2017-0049 |
0.385 |
|
| 2018 |
Dellazizzo L, Potvin S, O’Connor K, Dumais A. S58. A RANDOMIZED CONTROLLED TRIAL COMPARING VIRTUAL REALITY THERAPY TO COGNITIVE BEHAVIORAL THERAPY IN SCHIZOPHRENIA WITH TREATMENT REFRACTORY HALLUCINATIONS: PRELIMINARY RESULTS Schizophrenia Bulletin. 44: S346-S347. DOI: 10.1093/Schbul/Sby018.845 |
0.425 |
|
| 2017 |
Tikàsz A, Potvin S, Richard-Devantoy S, Lipp O, Hodgins S, Lalonde P, Lungu O, Dumais A. Reduced dorsolateral prefrontal cortex activation during affective Go/NoGo in violent schizophrenia patients: An fMRI study. Schizophrenia Research. PMID 29129509 DOI: 10.1016/J.Schres.2017.11.011 |
0.404 |
|
| 2017 |
Dugré JR, Dellazizzo L, Giguère CÉ, Potvin S, Dumais A. Persistency of Cannabis Use Predicts Violence following Acute Psychiatric Discharge. Frontiers in Psychiatry. 8: 176. PMID 28983261 DOI: 10.3389/Fpsyt.2017.00176 |
0.406 |
|
| 2017 |
Dellazizzo L, Potvin S, Giguère CÉ, Berwald M, Dugré JR, Dumais A. The psychometric properties of the Life History of Aggression evaluated in patients from a psychiatric emergency setting. Psychiatry Research. 257: 485-489. PMID 28841510 DOI: 10.1016/J.Psychres.2017.08.031 |
0.326 |
|
| 2017 |
Potvin S, Tikàsz A, Lungu O, Stip E, Zaharieva V, Lalonde P, Lipp O, Mendrek A. Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images. Frontiers in Psychiatry. 8: 109. PMID 28674507 DOI: 10.3389/Fpsyt.2017.00109 |
0.395 |
|
| 2017 |
Ouellet-Plamondon C, Abdel-Baki A, Salvat É, Potvin S. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes. Psychological Medicine. 47: 2461-2471. PMID 28424105 DOI: 10.1017/S0033291717000976 |
0.366 |
|
| 2017 |
Bourque J, Spechler PA, Potvin S, Whelan R, Banaschewski T, Bokde AL, Bromberg U, Büchel C, Quinlan EB, Desrivières S, Flor H, Frouin V, Gowland P, Heinz A, Ittermann B, et al. Functional Neuroimaging Predictors of Self-Reported Psychotic Symptoms in Adolescents. The American Journal of Psychiatry. appiajp201716080897. PMID 28320226 DOI: 10.1176/Appi.Ajp.2017.16080897 |
0.317 |
|
| 2016 |
Abdel-Baki A, Ouellet-Plamondon C, Salvat É, Grar K, Potvin S. Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program. Psychiatry Research. 247: 113-119. PMID 27888680 DOI: 10.1016/J.Psychres.2016.11.007 |
0.378 |
|
| 2016 |
Potvin S, Charbonneau G, Juster RP, Purdon S, Tourjman SV. Self-evaluation and objective assessment of cognition in major depression and attention deficit disorder: Implications for clinical practice. Comprehensive Psychiatry. 70: 53-64. PMID 27624423 DOI: 10.1016/J.Comppsych.2016.06.004 |
0.308 |
|
| 2016 |
Giguère CÉ, Potvin S. The Drug Abuse Screening Test preserves its excellent psychometric properties in psychiatric patients evaluated in an emergency setting. Addictive Behaviors. 64: 165-170. PMID 27614056 DOI: 10.1016/J.Addbeh.2016.08.042 |
0.321 |
|
| 2016 |
Potvin S, Lungu O, Tikàsz A, Mendrek A. Abnormal effective fronto-limbic connectivity during emotion processing in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 27528110 DOI: 10.1016/J.Pnpbp.2016.08.004 |
0.406 |
|
| 2016 |
Potvin S, Tikàsz A, Mendrek A. Emotionally Neutral Stimuli Are Not Neutral in Schizophrenia: A Mini Review of Functional Neuroimaging Studies. Frontiers in Psychiatry. 7: 115. PMID 27445871 DOI: 10.3389/Fpsyt.2016.00115 |
0.429 |
|
| 2016 |
Tikàsz A, Potvin S, Lungu O, Joyal CC, Hodgins S, Mendrek A, Dumais A. Anterior cingulate hyperactivations during negative emotion processing among men with schizophrenia and a history of violent behavior. Neuropsychiatric Disease and Treatment. 12: 1397-410. PMID 27366072 DOI: 10.2147/Ndt.S107545 |
0.401 |
|
| 2016 |
Potvin S, Stip E, Marchand S. Markedly Reduced Thermal Pain Perception in a Schizoaffective Patient with Tardive Dyskinesia. Case Reports in Psychiatry. 2016: 8702483. PMID 27144045 DOI: 10.1155/2016/8702483 |
0.39 |
|
| 2016 |
Potvin S, Lungu O, Lipp O, Lalonde P, Zaharieva V, Stip E, Melun JP, Mendrek A. Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings. Schizophrenia Research. 173: 30-6. PMID 27005897 DOI: 10.1016/J.Schres.2016.03.011 |
0.386 |
|
| 2016 |
Potvin S, Aubin G, Stip E. [Subjective cognition in schizophrenia]. L'Encephale. 43: 15-20. PMID 26923995 DOI: 10.1016/J.Encep.2016.01.002 |
0.426 |
|
| 2015 |
Zhornitsky S, Tikàsz A, Rizkallah É, Chiasson JP, Potvin S. Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis. Journal of Addiction. 2015: 843762. PMID 26417473 DOI: 10.1155/2015/843762 |
0.669 |
|
| 2015 |
Potvin S, Tikàsz A. Response to: A Commentary on "Antipsychotic-Induced Parkinsonism is Associated with Working Memory Deficits in Schizophrenia-Spectrum Disorders". Frontiers in Behavioral Neuroscience. 9: 210. PMID 26321931 DOI: 10.3389/Fnbeh.2015.00210 |
0.391 |
|
| 2015 |
Potvin S, Tikàsz A, Lungu O, Dumais A, Stip E, Mendrek A. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study. Schizophrenia Research. 168: 377-80. PMID 26255082 DOI: 10.1016/J.Schres.2015.07.046 |
0.391 |
|
| 2015 |
Mancini-Marïe A, Yoon U, Jiminez J, Fahim C, Potvin S, Grant JA, Laverdure-Dupont D, Dubé AA, Betrisey C, Rainville P, Evans AC, Stip E, Mendrek A. Sex, age, symptoms and illness duration and their relation with gyrification index in schizophrenia. Clinical Schizophrenia & Related Psychoses. PMID 26218234 DOI: 10.3371/Csrp.Mayo.070415 |
0.428 |
|
| 2015 |
Potvin S, Zhornitsky S, Stip E. Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: S26-34. PMID 25886677 |
0.594 |
|
| 2015 |
Potvin S, Lungu OV, Stip E. Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study. Journal of Clinical Psychopharmacology. 35: 82-3. PMID 25370126 DOI: 10.1097/Jcp.0000000000000236 |
0.376 |
|
| 2015 |
Potvin S, Aubin G, Stip E. Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders. European Archives of Psychiatry and Clinical Neuroscience. 265: 147-54. PMID 24925606 DOI: 10.1007/S00406-014-0511-Y |
0.449 |
|
| 2014 |
Potvin S, Lalonde M. [Psychosis and addiction: The evidence cemetery]. Santé Mentale Au QuéBec. 39: 75-98. PMID 25590545 |
0.342 |
|
| 2014 |
Potvin S, Stavro K, Rizkallah E, Pelletier J. Cocaine and cognition: a systematic quantitative review. Journal of Addiction Medicine. 8: 368-76. PMID 25187977 DOI: 10.1097/Adm.0000000000000066 |
0.304 |
|
| 2014 |
Horn M, Potvin S, Allaire JF, Côté G, Gobbi G, Benkirane K, Vachon J, Dumais A. Male inmate profiles and their biological correlates. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 59: 441-9. PMID 25161069 DOI: 10.1177/070674371405900807 |
0.338 |
|
| 2014 |
Grot S, Potvin S, Luck D. Is there a binding deficit in working memory in patients with schizophrenia? A meta-analysis. Schizophrenia Research. 158: 142-5. PMID 25048424 DOI: 10.1016/J.Schres.2014.06.012 |
0.345 |
|
| 2014 |
Paquin K, Wilson AL, Cellard C, Lecomte T, Potvin S. A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning? Bmc Psychiatry. 14: 139. PMID 24885300 DOI: 10.1186/1471-244X-14-139 |
0.375 |
|
| 2014 |
Samaha AN, Potvin S. Drugs of abuse and psychiatric disorders: neurobiological and clinical aspects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 52: 1-3. PMID 24699021 DOI: 10.1016/J.Pnpbp.2014.03.012 |
0.324 |
|
| 2013 |
Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, Potvin S. Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophrenia Research. 151: 43-7. PMID 24200418 DOI: 10.1016/J.Schres.2013.10.011 |
0.411 |
|
| 2013 |
Potvin S, Bourque J, Durand M, Lipp O, Lalonde P, Stip E, Grignon S, Mendrek A. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophrenia Research and Treatment. 2013: 543842. PMID 23970971 DOI: 10.1155/2013/543842 |
0.482 |
|
| 2013 |
Bourque J, Mendrek A, Durand M, Lakis N, Lipp O, Stip E, Lalonde P, Grignon S, Potvin S. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry Research. 214: 24-32. PMID 23906663 DOI: 10.1016/J.Pscychresns.2013.05.012 |
0.435 |
|
| 2013 |
Zhornitsky S, Wee Yong V, Koch MW, Mackie A, Potvin S, Patten SB, Metz LM. Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair. Cns Neuroscience & Therapeutics. 19: 737-44. PMID 23870612 DOI: 10.1111/Cns.12154 |
0.604 |
|
| 2013 |
Zhornitsky S, Aubin G, Desfossés J, Rizkallah E, Pampoulova T, Lipp O, Chiasson JP, Stip E, Potvin S. Predictors of community functioning in schizophrenia and substance use disorder patients. Community Mental Health Journal. 49: 317-22. PMID 22847727 DOI: 10.1007/S10597-012-9525-Y |
0.701 |
|
| 2013 |
Stavro K, Rizkallah E, Dinh-Williams L, Chiasson J, Potvin S. Hypersexuality among a Substance Use Disorder Population Sexual Addiction & Compulsivity. 20: 210-216. DOI: 10.1080/10720162.2013.787379 |
0.338 |
|
| 2012 |
Zhornitsky S, Potvin S. Cannabidiol in humans-the quest for therapeutic targets. Pharmaceuticals (Basel, Switzerland). 5: 529-52. PMID 24281562 DOI: 10.3390/Ph5050529 |
0.66 |
|
| 2012 |
Lévesque M, Potvin S, Marchand S, Stip E, Grignon S, Pierre L, Lipp O, Goffaux P. Pain perception in schizophrenia: evidence of a specific pain response profile. Pain Medicine (Malden, Mass.). 13: 1571-9. PMID 23170852 DOI: 10.1111/J.1526-4637.2012.01505.X |
0.327 |
|
| 2012 |
Desfossés J, Stip E, Bentaleb LA, Lipp O, Chiasson JP, Furtos A, Venne K, Kouassi E, Potvin S. Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. Frontiers in Psychiatry. 3: 85. PMID 23055987 DOI: 10.3389/Fpsyt.2012.00085 |
0.485 |
|
| 2012 |
Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Lipp O, Stip E, Potvin S. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Psychiatry Research. 200: 237-41. PMID 22980481 DOI: 10.1016/J.Psychres.2012.07.046 |
0.706 |
|
| 2012 |
Potvin S, Morin M, Cloutier C, Gendron A, Bissonnette A, Marchand S. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial. Journal of Clinical Psychopharmacology. 32: 684-7. PMID 22926604 DOI: 10.1097/Jcp.0B013E318267B8Ca |
0.331 |
|
| 2012 |
Tourjman V, Koué M, Kouassi E, Potvin S. <i>In vivo</i> immunomodulatory effects of antipsychotics on inflammatory mediators: A review Advances in Bioscience and Biotechnology. 3: 551-565. DOI: 10.4236/Abb.2012.324072 |
0.336 |
|
| 2012 |
Potvin S, Stavro K, Pelletier J. Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors Journal of Dual Diagnosis. 8: 35-47. DOI: 10.1080/15504263.2012.648549 |
0.439 |
|
| 2011 |
Stip E, Zhornitsky S, Moteshafi H, Létourneau G, Stikarovska I, Potvin S, Tourjman V. Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile. Clinical Therapeutics. 33: 1853-67. PMID 22133697 DOI: 10.1016/J.Clinthera.2011.10.027 |
0.65 |
|
| 2011 |
Rizkallah E, Bélanger M, Stavro K, Dussault M, Pampoulova T, Chiasson JP, Potvin S. Could the use of energy drinks induce manic or depressive relapse among abstinent substance use disorder patients with comorbid bipolar spectrum disorder? Bipolar Disorders. 13: 578-80. PMID 22017226 DOI: 10.1111/J.1399-5618.2011.00951.X |
0.355 |
|
| 2011 |
Rizkallah E, Legault L, Pampoulova T, Lévesque S, Bélanger M, Stavro K, Chiasson JP, Potvin S. A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 478-9. PMID 21838849 DOI: 10.1111/J.1521-0391.2011.00158.X |
0.343 |
|
| 2011 |
Zhornitsky S, Stip E, Desfossés J, Pampoulova T, Rizkallah E, Rompré PP, Bentaleb LA, Lipp O, Chiasson JP, Gendron A, Potvin S. Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine. Frontiers in Psychiatry. 2: 22. PMID 21629845 DOI: 10.3389/Fpsyt.2011.00022 |
0.717 |
|
| 2011 |
Igue R, Potvin S, Bah R, Stip E, Bouchard RH, Lipp O, Gendron A, Kouassi E. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1695-8. PMID 21627977 DOI: 10.1016/J.Pnpbp.2011.05.011 |
0.417 |
|
| 2011 |
Dumais A, Potvin S, Joyal C, Allaire JF, Stip E, Lesage A, Gobbi G, Côté G. Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders. Schizophrenia Research. 130: 234-7. PMID 21441016 DOI: 10.1016/J.Schres.2011.02.024 |
0.419 |
|
| 2011 |
Paul-Savoie E, Potvin S, Daigle K, Normand E, Corbin JF, Gagnon R, Marchand S. A deficit in peripheral serotonin levels in major depressive disorder but not in chronic widespread pain. The Clinical Journal of Pain. 27: 529-34. PMID 21415718 DOI: 10.1097/Ajp.0B013E31820Dfede |
0.327 |
|
| 2011 |
Zhornitsky S, Potvin S, Moteshafi H, Dubreucq S, Rompré PP, Stip E. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. International Clinical Psychopharmacology. 26: 183-92. PMID 21372722 DOI: 10.1097/Yic.0B013E3283430A0E |
0.668 |
|
| 2011 |
Zhornitsky S, Potvin S, Aubin G, Stip E. Relationship between insight into cognition, extrapyramidal symptoms and mental illness in schizophrenia. The Australian and New Zealand Journal of Psychiatry. 45: 604-5. PMID 21355813 DOI: 10.3109/00048674.2011.561483 |
0.678 |
|
| 2011 |
Chiasson JP, Rizkallah É, Stavro K, Dussault M, Pampoulova T, Tourjman V, Potvin S. Is the Mood Disorder Questionnaire an appropriate screening tool in detecting bipolar spectrum disorder among substance use populations? The American Journal of Drug and Alcohol Abuse. 37: 79-81. PMID 21142433 DOI: 10.3109/00952990.2010.538944 |
0.327 |
|
| 2011 |
Moteshafi H, Zhornitsky S, Dubreucq S, Rompré PP, Potvin S, Stip E. Tolerability of quetiapine across psychiatric disorders International Clinical Psychopharmacology. 26: e149. DOI: 10.1097/01.Yic.0000405887.17709.6D |
0.63 |
|
| 2011 |
Bah R, Igue R, Potvin S, Stip E, Bouchard R, Lipp O, Gendron A, Kouassi E. Markedly elevated plasma levels of interleukin-1 receptor antagonist in patients with dual diagnosis of schizophrenia and substance use disorders International Clinical Psychopharmacology. 26: e148. DOI: 10.1097/01.Yic.0000405886.17709.24 |
0.405 |
|
| 2010 |
Rizkallah E, Stip E, Zhornitsky S, Pampoulova T, Gendron A, Rompré PP, Chiasson JP, Potvin S. Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial. Expert Opinion On Pharmacotherapy. 11: 2947-51. PMID 20979569 DOI: 10.1517/14656566.2010.524927 |
0.681 |
|
| 2010 |
Zhornitsky S, Stip E, Pampoulova T, Rizkallah E, Lipp O, Bentaleb LA, Chiasson JP, Potvin S. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2188-94. PMID 20669315 DOI: 10.1002/Mds.23227 |
0.709 |
|
| 2010 |
Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Stip E, Rompré PP, Potvin S. Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. Journal of Clinical Psychopharmacology. 30: 417-24. PMID 20631559 DOI: 10.1097/Jcp.0B013E3181E7810A |
0.667 |
|
| 2010 |
Zhornitsky S, Potvin S, Stip E, Rompré PP. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 695-703. PMID 20605419 DOI: 10.1016/J.Euroneuro.2010.04.011 |
0.624 |
|
| 2010 |
Stip E, Zhornitsky S, Potvin S, Tourjman V. Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 997-1000. PMID 20470848 DOI: 10.1016/J.Pnpbp.2010.05.010 |
0.663 |
|
| 2010 |
Villeneuve K, Potvin S, Lesage A, Nicole L. Meta-analysis of rates of drop-out from psychosocial treatment among persons with schizophrenia spectrum disorder Schizophrenia Research. 121: 266-270. PMID 20452749 DOI: 10.1016/J.Schres.2010.04.003 |
0.411 |
|
| 2010 |
Desfossés J, Stip E, Bentaleb LA, Potvin S. Endocannabinoids and Schizophrenia Pharmaceuticals. 3: 3101-3126. DOI: 10.3390/Ph3103101 |
0.418 |
|
| 2010 |
Salvat E, Abdel-Baki A, Nicole L, Potvin S, Ouellet-Plamondon C, Artaud L, Granger B, Stip E, Lesage A, Lalonde P. IMPACT OF SUBSTANCE USE DISORDER ON FUNCTIONAL OUTCOME IN FIRST-EPISODE PSYCHOSIS: A 2 YEARS PROSPECTIVE STUDY WITHIN THE UNIVERSITé DE MONTRéAL NETWORK Schizophrenia Research. 117: 424. DOI: 10.1016/J.Schres.2010.02.780 |
0.332 |
|
| 2009 |
Potvin S, Blanchet P, Stip E. Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophrenia Research. 113: 181-8. PMID 19608386 DOI: 10.1016/J.Schres.2009.06.010 |
0.452 |
|
| 2009 |
de Souza JB, Potvin S, Goffaux P, Charest J, Marchand S. The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. The Clinical Journal of Pain. 25: 123-7. PMID 19333157 DOI: 10.1097/Ajp.0B013E318183Cfa4 |
0.309 |
|
| 2009 |
Potvin S. Neuroimaging Studies of Substance Abuse in Schizophrenia Current Psychiatry Reviews. 5: 250-260. DOI: 10.2174/157340009789542169 |
0.447 |
|
| 2008 |
Potvin S, Pampoulova T, Lipp O, Ait Bentaleb L, Lalonde P, Stip E. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. Cognitive Neuropsychiatry. 13: 357-66. PMID 18622790 DOI: 10.1080/13546800802264330 |
0.468 |
|
| 2008 |
Stip E, Mancini-Marïe A, Fahim C, Bentaleb LA, Létourneau G, Potvin S. Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patients. Schizophrenia Research. 103: 319-21. PMID 18556174 DOI: 10.1016/J.Schres.2008.04.030 |
0.421 |
|
| 2008 |
Potvin S, Kouassi E, Lipp O, Bouchard RH, Roy MA, Demers MF, Gendron A, Astarita G, Piomelli D, Stip E. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. Journal of Psychopharmacology (Oxford, England). 22: 262-9. PMID 18308802 DOI: 10.1177/0269881107083816 |
0.488 |
|
| 2008 |
Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. The American Journal of Drug and Alcohol Abuse. 34: 75-82. PMID 18161645 DOI: 10.1080/00952990701764631 |
0.438 |
|
| 2008 |
Potvin S, Marchand S. Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies. Pain. 138: 70-8. PMID 18160219 DOI: 10.1016/J.Pain.2007.11.007 |
0.428 |
|
| 2008 |
Potvin S, Stip E, Tempier A, Pampoulova T, Bentaleb LA, Lalonde P, Lipp O, Goffaux P, Marchand S. Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. Journal of Psychiatric Research. 42: 1010-6. PMID 18093615 DOI: 10.1016/J.Jpsychires.2007.11.001 |
0.344 |
|
| 2008 |
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biological Psychiatry. 63: 801-8. PMID 18005941 DOI: 10.1016/J.Biopsych.2007.09.024 |
0.369 |
|
| 2008 |
Potvin S, Joyal CC, Pelletier J, Stip E. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophrenia Research. 100: 242-51. PMID 17614260 DOI: 10.1016/J.Schres.2007.04.022 |
0.428 |
|
| 2008 |
Potvin S, Mancini-Marie A, Fahim C, Mensour B, Lèvesque J, Karama S, Beauregard M, Stip E. REGIONS OF INTEREST ANALYSES OF FRONTAL, TEMPORAL AND SUB-CORTICAL GREY MATTER IN SCHIZOPHRENIA USING VOXEL-BASED MORPHOMETRY Schizophrenia Research. 102: 82. DOI: 10.1016/S0920-9964(08)70250-0 |
0.363 |
|
| 2007 |
Potvin S, Mancini-Marie A, Fahim C, Mensour B, Stip E. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Social Neuroscience. 2: 106-16. PMID 18633810 DOI: 10.1080/17470910701376787 |
0.473 |
|
| 2007 |
Potvin S, Sepehry AA, Stip E. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. The Australian and New Zealand Journal of Psychiatry. 41: 792-9. PMID 17828652 DOI: 10.1080/00048670701579041 |
0.392 |
|
| 2007 |
Ben Amar M, Potvin S. Cannabis and psychosis: what is the link? Journal of Psychoactive Drugs. 39: 131-42. PMID 17703707 DOI: 10.1080/02791072.2007.10399871 |
0.397 |
|
| 2007 |
Fahim C, Stip E, Mancini-Marïe A, Potvin S, Malaspina D. Orbitofrontal dysfunction in a monozygotic twin discordant for postpartum affective psychosis: a functional magnetic resonance imaging study. Bipolar Disorders. 9: 541-5. PMID 17680927 DOI: 10.1111/J.1399-5618.2007.00404.X |
0.381 |
|
| 2007 |
Sepehry AA, Potvin S, Elie R, Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. The Journal of Clinical Psychiatry. 68: 604-10. PMID 17474817 DOI: 10.4088/Jcp.V68N0417 |
0.395 |
|
| 2007 |
Potvin S, Mancini-Marïe A, Fahim C, Mensour B, Lévesque J, Karama S, Beauregard M, Rompré PP, Stip E. Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Research. 154: 275-9. PMID 17341445 DOI: 10.1016/J.Pscychresns.2006.11.009 |
0.46 |
|
| 2007 |
Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. European Psychiatry : the Journal of the Association of European Psychiatrists. 22: 104-15. PMID 17227707 DOI: 10.1016/J.Eurpsy.2006.11.004 |
0.417 |
|
| 2007 |
Potvin S, Sepehry AA, Stip E. Comorbid substance-use in schizophrenia: the file drawer effect, In reply to: Talamo et al., 2006. "Comorbid substance-use in schizophrenia: relation to positive and negative symptoms". Schizophrenia Research. 90: 351-2; author reply . PMID 17055705 DOI: 10.1016/J.Schres.2006.09.006 |
0.43 |
|
| 2006 |
Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Current Medical Research and Opinion. 22: 1277-85. PMID 16834826 DOI: 10.1185/030079906X112561 |
0.477 |
|
| 2006 |
Potvin S, Pampoulova T, Mancini-Marië A, Lipp O, Bouchard RH, Stip E. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 796-8. PMID 16705205 DOI: 10.1136/JNNP.2005.079228 |
0.375 |
|
| 2006 |
Mancini-Marïe A, Potvin S, Fahim C, Beauregard M, Mensour B, Stip E. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study. The Journal of Clinical Psychiatry. 67: 342-50. PMID 16649818 DOI: 10.4088/Jcp.V67N0302 |
0.478 |
|
| 2006 |
Potvin S, Sepehry AA, Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological Medicine. 36: 431-40. PMID 16536885 DOI: 10.1017/S003329170500574X |
0.425 |
|
| 2005 |
Potvin S, Briand C, Prouteau A, Bouchard RH, Lipp O, Lalonde P, Nicole L, Lesage A, Stip E. CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain and Cognition. 59: 38-42. PMID 15913868 DOI: 10.1016/J.Bandc.2005.04.002 |
0.455 |
|
| 2005 |
Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini-Marie A, Stip E. The paradox of quetiapine in obsessive-compulsive disorder. Cns Spectrums. 10: 356-61. PMID 15858452 DOI: 10.1017/S1092852900022719 |
0.463 |
|
| 2005 |
Potvin S, Stip E, Roy J. Toxic Psychoses as Pharmacological Models of Schizophrenia Current Psychiatry Reviews. 1: 23-32. DOI: 10.2174/1573400052953583 |
0.457 |
|
| 2004 |
Potvin S, Stip E, Roy JY. The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 711. PMID 15560324 DOI: 10.1177/070674370404901020 |
0.458 |
|
| 2003 |
Potvin S, Stip E, Roy JY. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. International Clinical Psychopharmacology. 18: 121-32. PMID 12702890 DOI: 10.1097/01.Yic.0000063501.97247.38 |
0.422 |
|
| Show low-probability matches. |